Table 1.
Comparison of Baseline Characteristics of Medical and Surgical Cohorts
| Medical treatment (n=58) | Surgical treatment (n=222) | ||||
|---|---|---|---|---|---|
| Demographics: | Mean (SD) | N(%) | Mean (SD) | N (%) | p-value |
| Follow-up (mos.) | 11.6 (5.3) | 12.1 (5.6) | 0.543 | ||
| Age (yrs) | 50.3 (15.0) | 51.9 (14.6) | 0.487 | ||
| Males | 23 (39.7) | 119 (53.6) | |||
| Females | 35 (60.3) | 103 (46.4) | 0.358 | ||
| White/Caucasian | 51 (87.9) | 187 (84.2) | 0.438 | ||
| African American | 3 (5.2) | 12 (5.4) | >0.999 | ||
| Asian | 1 (1.7) | 9 (4.1) | 0.693 | ||
| American Indian/Native Alaskan | 2 (3.4) | 1 (0.5) | 0.110 | ||
| Hispanic/Latino | 0 (0.0) | 13 (5.9) | 0.077 | ||
| Medical comorbidity: | |||||
| Asthma | 15 (25.9) | 84 (37.8) | 0.089 | ||
| Nasal polyposis | 20 (34.5) | 80 (36.0) | 0.826 | ||
| Allergies (test confirmed) | 20 (34.5) | 88 (39.6) | 0.472 | ||
| ASA sensitivity | 6 (10.3) | 16 (7.2) | 0.429 | ||
| Depression | 12 (20.7) | 42 (18.9) | 0.761 | ||
| Tobacco use | 1 (1.7) | 13 (5.9) | 0.314 | ||
| Previous sinus surgery | 34 (58.6) | 120 (54.1) | 0.534 | ||
| Baseline disease severity: | |||||
| SNOT-22 score | 46.3 (18.3) | 52.9 (19.0) | 0.018 | ||
| RSDI score | 38.3 (23.5) | 46.2 (25.0) | 0.030 | ||
| RSDI physical score | 16.6 (9.5) | 18.2 (9.0) | 0.248 | ||
| RSDI functional score | 12.3 (7.9) | 15.1 (9.0) | 0.030 | ||
| RSDI emotional score | 9.4 (8.1) | 12.9 (9.0) | 0.007 | ||
| Computed tomography score | 13.4 (6.0) | 12.1 (5.8) | 0.132 | ||
| Endoscopy score | 6.9 (4.3) | 6.0 (3.8) | 0.128 | ||
| B-SIT olfaction score | 8.8 (3.2) | 9.0 (3.2) | 0.703 | ||
SD, standard deviation; mos., months; yrs, years; ASA, acetylsalicylic acid, SNOT-22, 22-item SinoNasal Outcome Test; RSDI, Rhinosinusitis Disability Index, B-SIT, Brief Smell Identification Test